Mirova’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $21.3M | Sell |
250,208
-3,603
| -1% | -$326K | 0.79% | 36 |
|
|
2026
Q2 | $23.3M | Buy |
253,811
+138,998
| +121% | +$12.2M | 0.86% | 32 |
|
|
2026
Q1 | $9.8M | Sell |
114,813
-23,185
| -17% | -$2.07M | 0.4% | 83 |
|
|
2025
Q4 | $10.9M | Sell |
137,998
-4,189
| -3% | -$328K | 1.57% | 17 |
|
|
2025
Q3 | $11.4M | Buy |
142,187
+11,168
| +9% | +$953K | 1.61% | 16 |
|
|
2025
Q2 | $11.9M | Buy |
131,019
+58,759
| +81% | +$5.36M | 1.68% | 14 |
|
|
2025
Q1 | $6.77M | Sell |
72,260
-21,087
| -23% | -$1.89M | 1.22% | 18 |
|
|
2024
Q4 | $8.49M | Buy |
93,347
+6,693
| +8% | +$639K | 1.46% | 14 |
|
|
2024
Q3 | $9M | Sell |
86,654
-11,692
| -12% | -$1.19M | 1.55% | 13 |
|
|
2024
Q2 | $9.5M | Buy |
98,346
+3,118
| +3% | +$288K | 1.74% | 11 |
|
|
2024
Q1 | $8.58M | Buy |
95,228
+39,636
| +71% | +$3.36M | 1.52% | 12 |
|
|
2023
Q4 | $4.43M | Sell |
55,592
-91
| -0.2% | -$6.84K | 0.91% | 24 |
|
|
2023
Q3 | $3.96M | Sell |
55,683
-7,771
| -12% | -$581K | 0.8% | 31 |
|
|
2023
Q2 | $4.89M | Sell |
63,454
-6,441
| -9% | -$499K | 0.86% | 23 |
|
|
2023
Q1 | $5.25M | Sell |
69,895
-5,359
| -7% | -$398K | 0.76% | 23 |
|
|
2022
Q4 | $5.93M | Buy |
75,254
+14,100
| +23% | +$1.06M | 0.93% | 13 |
|
|
2022
Q3 | $4.3M | Sell |
61,154
-12,458
| -17% | -$977K | 0.72% | 19 |
|
|
2022
Q2 | $5.9M | Buy |
73,612
+13,908
| +23% | +$1.09M | 0.84% | 19 |
|
|
2022
Q1 | $4.53M | Buy |
59,704
+165
| +0.3% | +$13.1K | 0.61% | 24 |
|
|
2021
Q4 | $5.08M | Buy |
59,539
+17,392
| +41% | +$1.36M | 0.61% | 19 |
|
|
2021
Q3 | $3.18M | Buy |
42,147
+1,257
| +3% | +$100K | 0.41% | 32 |
|
|
2021
Q2 | $3.33M | Buy |
40,890
+846
| +2% | +$69.2K | 0.4% | 34 |
|
|
2021
Q1 | $3.16M | Buy |
40,044
+12,287
| +44% | +$963K | 0.38% | 31 |
|
|
2020
Q4 | $2.37M | Buy |
27,757
+7,488
| +37% | +$619K | 0.31% | 30 |
|
|
2020
Q3 | $1.56M | Buy |
20,269
+5,102
| +34% | +$389K | 0.25% | 35 |
|
|
2020
Q2 | $1.11M | Buy |
15,167
+3,353
| +28% | +$238K | 0.26% | 37 |
|
|
2020
Q1 | $784K | Buy |
11,814
+5,764
| +95% | +$407K | 0.3% | 33 |
|
|
2019
Q4 | $416K | Buy |
6,050
+4,039
| +201% | +$275K | 0.14% | 43 |
|
|
2019
Q3 | $148K | Buy |
2,011
+106
| +6% | +$7.69K | 0.02% | 80 |
|
|
2019
Q2 | $137K | Buy |
1,905
+1,072
| +129% | +$76.1K | 0.01% | 78 |
|
|
2019
Q1 | $57K | Buy |
+833
| New | +$53.8K | 0.03% | 85 |
|
Other funds holding CL
Mirova's CL Position: Q3 2026 in Review
Mirova reduced its Colgate-Palmolive (CL) stake by 1.4% in Q3 2026, selling an estimated $326K and leaving 250,208 shares worth $21.3M. The position accounts for 0.79% of the portfolio, ranked #36.
Mirova first reported a position in CL in Q1 2019 and has held it in 31 quarters since. The position peaked at $23.3M in Q2 2026. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.
- Mirova held 250,208 shares of Colgate-Palmolive worth $21.3M as of Q3 2026.
- Mirova sold 3,603 Colgate-Palmolive shares in Q3 2026, an estimated $326K.
- Colgate-Palmolive made up 0.79% of Mirova's portfolio in Q3 2026, its #36 holding.
- Mirova first reported a position in Colgate-Palmolive in Q1 2019 and has held it in 31 quarters since.
- Mirova's Colgate-Palmolive position peaked at $23.3M in Q2 2026.
- 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.
Based on Mirova's 13F filing for Q3 2026, filed 13 Nov 2026.